The mammalian translocon is assembled from four core proteins (the heterotrimeric Sec61α, Sec61β, Sec61γ, and translocating nascent chain--associated membrane protein \[TRAM\]) and various accessory proteins, only some of which have well-defined functions (e.g., the signal peptidase and the oligosaccharyltransferase; [@bib9]). This assembly forms the aqueous, gated pore that transports nascent proteins through the membrane ([@bib3]). Because two molecular machines, the ribosome and the translocon, function simultaneously on the same nascent protein during cotranslational protein trafficking, they presumably function together as a unit (the ribosome--translocon complex \[RTC\]) that includes all proteins regularly associated with the translocon. Yet these machines are commonly treated as separate entities in papers and talks; ribosomologists tend to assume that membrane-bound ribosomes are indistinguishable from free ribosomes except for their location, whereas translocophiles tend to consider the ribosome simply a source of substrate that docks on the translocon. However, the results published in this issue (see Pool on p. 889) demonstrate that the identity of the nascent chain being synthesized alters RTC structure, thereby revealing that the two machines are indeed coupled.

The nascent chain moves through the large ribosomal subunit via an ∼100-Å-long tunnel that is contiguous with the aqueous pore formed by the translocon ([Fig. 1 A](#fig1){ref-type="fig"}; [@bib3]; [@bib1]; [@bib8]). Nascent chain control of protein trafficking from inside the ribosome was first identified when the location of a nascent chain transmembrane segment (TMS) in the tunnel was found to dictate whether the nascent chain was exposed to the cytosolic, lumenal, or neither side of the ER membrane ([@bib7]). It was postulated that a weakly nonpolar patch in the tunnel nucleated the folding of the TMS into an α-helix, which in turn elicited conformational changes in the RTC that triggered complementary changes at each end of the pore to minimize ion passage/leakage through the translocon during integration. A later study revealed that ribosome-induced folding of a nascent chain TMS did occur, and this folding coincided with TMS photocrosslinking to Rpl17 at a constriction in the tunnel ([Fig. 1 B](#fig1){ref-type="fig"}; [@bib16]), a site formed in part by a loop of Rpl17 that extends far into the large ribosomal subunit ([@bib8]; [@bib2]).

![**Nascent chain control of translocon structure from inside the ribosome.** (A and B) A nascent secretory protein is fully extended during synthesis (A), whereas the TMS in a nascent membrane protein (B) folds into an α-helix upon reaching a tunnel constriction formed by Rpl4 and Rpl17. Although Sec61β is always adjacent to Rpl17 in an RTC, RAMP4 is recruited to the RTC and is cross-linked to Rpl17 only when a TMS reaches the constriction. The cross-linking of Rpl17 to a TMS and to RAMP4 coincides with the BiP-mediated closure (either directly, as depicted, or indirectly) of the lumenal end of the aqueous pore and the subsequent opening of the ion-tight ribosome--translocon junction (depicted by a tilting of the ribosomal subunit). PTC, peptidyl transferase center.](JCB_200902014_RGB_Fig1){#fig1}

[@bib26] found that ribosomal protein Rpl17, located primarily at the ribosomal surface near the tunnel exit, was chemically cross-linked to Sec61β, thereby showing that Sec61β is adjacent to Rpl17 in all RTCs. But when the ribosome was synthesizing a membrane protein, Rpl17 also cross-linked to RAMP4, a small ribosome-associated membrane protein associated with the translocon ([@bib12]). Strikingly, Rpl17 cross-linking to RAMP4 was detected only after the TMS in the nascent chain reached the tunnel constriction ([Fig. 1 B](#fig1){ref-type="fig"}). The coincidence of these two cross-linking events, TMS to Rpl17 and Rpl17 to RAMP4, indicates that direct contact between the nascent chain TMS and Rpl17 inside the tunnel triggered a conformational change that was transmitted through the Rpl17 extension to the ribosomal surface and that stimulated RAMP4 association with the RTC close to Rpl17. Thus, a structural feature found only in nascent membrane proteins caused a structural realignment of the RTC. This change correlates with the transition of RTC operations from translocation to integration seen in earlier studies ([@bib7]; [@bib4]; [@bib16]).

The data shown by [@bib26] also demonstrate that the translocon, at least in mammals, is not as structurally defined as has been portrayed. Uncertainties in the composition, stoichiometry, exchangeability, and macromolecular arrangement of the core and associated translocon proteins, as well as translocon dynamics and homogeneity, have been recognized for some time ([@bib6]), but only recently have translocon heterogeneity ([@bib14]; [@bib13]), conformational changes ([@bib5]), and exchangeable membrane proteins (e.g., importin α-16 appears to be a sorting factor for inner nuclear membrane proteins; [@bib10], [@bib11]) been documented. The data now show that RAMP4 in the bilayer associates with the RTC near Rpl17 when a TMS binds Rpl17 inside the ribosome [@bib26]. Thus, translocon structure is dynamic and involves more proteins than the core Sec61α, Sec61β, Sec61γ, and TRAM proteins. Equally important, as shown by [@bib26], translocon structure can be altered by a nascent chain structural feature from inside the ribosome. Thus, the structures of the ribosome and translocon are intimately coupled, and the conversion of the RTC from one functional state to another involves structural changes (e.g., the introduction of a new protein) not accommodated in current models of translocon structure and function.

The study by [@bib26] also emphasizes the importance of using multiple approaches to examine complex systems, especially those containing membranes. Protein crystallography and cryo-EM have made tremendous strides recently in describing the structures of molecular assemblies such as the ribosome and translocon ([@bib1]; [@bib8]; [@bib2]; [@bib15]), and it is difficult to overstate how important those studies have been in terms of influencing subsequent RTC research. Yet no single technique is a panacea, and the data shown by [@bib26] dramatically highlight the limitations of assuming that crystallographic and cryo-EM studies provide all that one needs to understand the structural aspects of how a machine works, much less the functional, mechanistic, and/or regulatory aspects. For example, RAMP4, the core protein TRAM, and other translocon-associated proteins have not been identified in cryo-EM images of the detergent-solubilized RTC as a result of their small size, flexibility, and/or weak association with the Sec61 core. Similarly, the existence of ribosome-induced TMS folding inside the ribosome tunnel and its regulation of nascent chain accessibility to alternate sides of the ER membrane would not have been detected with samples that had been detergent-treated and lacked water, the lipid bilayer, and some of the core and associated translocon proteins. Thus, although models derived from crystallographic and cryo-EM images of detergent-treated, incomplete, anhydrous, and nonfunctional RTC samples may prove to be accurate, well-designed experiments and controls using intact samples in aqueous solution must be performed to directly correlate structural and functional states and thereby fully appreciate subtle and sophisticated operational and regulatory mechanisms that do not withstand harsh treatment.

There is much left to learn about the RTC. Rpl17 acts as a direct communication conduit between a TMS in the tunnel and the translocon, but it remains to be seen whether RAMP4 then mediates transmembrane communication and triggers BiP binding. Similarly, RAMP4 interactions with the RTC have not been characterized nor have the protein composition, arrangement, and dynamics of the mammalian ER translocon in intact membranes. Thus, additional intriguing surprises are ahead.
